We investigated the role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography
(PET) in the early evaluation of response to chemotherapy in metastatic breast cancer …

Background An advantage of PET/CT has been demonstrated for diagnosis of several tumor
entities. In patients with breast cancer, early diagnosis and accurate restaging of recurrence …

BACKGROUND: In this retrospective, single‐institution study, the authors examine the
maximum standardized uptake value (SUVmax) on positron emission tomography/computed …

Background The response of bone-dominant (BD) breast cancer to therapy is difficult to
assess by conventional imaging. Our preliminary studies have shown that quantitative serial …

Purpose We evaluated whether 18 F-3′-deoxy-3′-fluorothymidine positron emission
tomography (FLT PET) can predict the final postoperative histopathological response in …

Abstract The applications of 2-deoxy-2-[18 F] fluoro-d-glucose positron emission
tomography/X-ray computed tomography (PET/CT) in the management of patients with …

Purpose We compared the ability of 68Ga-FAPI PET//CT with 18FDG PET/CT imaging
techniques to detect additional lesions in breast cancer patients that may affect further …

Background: The aim of this was to evaluate FDG-PET (2-(fluorine-18)-fluoro-2-deoxy-D-
glucose positron emission tomography) for assessment of residual tumour after primary …

FDG PET has emerged as an important clinical imaging modality for diagnosing and staging
cancer. However, the impact of FDG PET on staging and managing patients with breast …

AIM: While it is well-known that there is 18F-FDG uptake in breast tumors, clinical impact of
(18) F-FDG PET in managing breast cancer patients is not well-studied. METHODS: One …